Fatty acid facts, Part II: Role in the prevention of carcinogenesis, or, more fish on the dish?

Drug News and Perspectives

Volumn 21, Issue 9, 2008, Pages 504-510

  Pauwels, Ernest K J ^a   Kairemo, Kalevi ^b  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID DERIVATIVE; CYTOCHROME P450; DOCOSAHEXAENOIC ACID; FREE RADICAL; GAMMA LINOLENIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CANCER RISK; CARCINOGENESIS; COLORECTAL CANCER; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; NONHUMAN; PROSTATE CANCER; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; DIET; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; FISHES; HUMANS; MALE; NEOPLASMS; PROSTATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 61849161135     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: 10.1358/dnp.2008.21.9.1290819     Document Type: Review

References (52)

1. Roynette, C.E., Calder, P.C., Dupertuis, Y.M. and Pichard, C. n-3 polyunsaturated fatty acids and colon cancer prevention. Clin Nutr 2004, 23(2): 139-51.
2. Kato, T., Kolenic, N. and Pardini, R.S. Docosahexaenoic acid (DHA), a primary tumor suppressive omega-3 fatty acid, inhibits growth of colorectal cancer independent of p53 mutational status. Nutr Cancer 2007, 58(2): 178-87.
3. Calviello, G, Serini, S. and Piccioni, E. n-3 polyunsaturated fatty acids and the prevention of colorectal cancer: molecular mechanisms involved. Curr Med Chem 2007, 14(29): 3059-69.
4. Terry, P.D., Rohan, T.E. and Welk, A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: a review of the epidemiologic evidence. Am J Clin Nutr 2003, 77(3): 532-43.
5. Norat, T., Bingham, S., Ferrari, P. et al. Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 2005, 97(12): 906-16.
6. Hall, M.N., Chavarro, J.E., Lee, I.M., Willett, W.C. and Ma, J. A 22-year prospective study of fish, n-3 fatty acid intake, and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 2008, 17(5): 1136-43.
7. Lands, W.E., Hamazaki, T., Yamazaki, K., Okuyama, H., Sakai, K., Goto, Y. and Hubbard, V.S. Changing dietary patterns. Am J Clin Nutr 1990, 51(6): 991-3.
8. Cunname, S.C. Problems with essential fatty acids: Time for a new paradigm? Prog Lipid Res 2003, 42(6): 544-68.
9. Simopoulos, A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008, 233(6): 674-88.
10. Qualtrough, D., Kaidi, A., Chell, S., Jabbour, H.N., Williams, A.C. and Paraskeva, C. Prostaglandin F(2alpha) stimulates motility and invasion in colorectal tumor cells. Int J Cancer 2007, 121(4): 734-40.
11. Hofseth, L.J. Nitric oxide as a target of complementary and alternative medicines to prevent and treat inflammation and cancer. Cancer Lett 2008, 268(1): 10-30.
12. Kundu, J.K. and Surh, Y.J. Inflammation: Gearing the journey to cancer. Mutat Res 2008, 659(1-2): 15-30.
13. Grau, R., Iñiguez, M.A. and Fresno, M. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12, 14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Cancer Res 2004, 64(15): 5162-71.
14. Mahipal, S.V., Subhashini, J., Reddy, M.C. et al. Effect of 15-lipoxygenase metabolites, 15-(S)-HPETE and 15-(S)-HETE on chronic myelogenous leukemia cell line K-562: reactive oxygen species (ROS) mediate caspase-dependent apoptosis. Biochem Pharmacol 2007, 74(2): 202-14.
15. Cerchietti, L.C., Navigante, A.H. and Castro, M.A. Effects of eicosapentaenoic and docosahexaenoic n-3 fatty acids from fish oil and preferential Cox-2 inhibition on systemic syndromes in patients with advanced lung cancer. Nutr Cancer 2007, 59(1): 14-20.
16. Ringbom, T., Huss, U., Stenholm, A., Flock, S., Skattebol, L., Perera, P. and Bohlin, L. Cox-2 inhibitory effects of naturally occurring and modified fatty acids. J Nat Prod 2001, 64(6): 745-9.
17. Badawi, A.F., El-Sohemy, A., Stephen, L.L., Ghoshal, A.K. and Archer, M.C. The effect of dietary n-3 and n-6 polyunsaturated fatty acids on the expression of cyclooxygenase 1 and 2 and levels of p21ras in rat mammary glands. Carcinogenesis 1998, 19(5): 905-10.
18. Yacoubian, S. and Serhan, C.N. New endogenous anti-inflammatory and proresolving lipid mediators: implications for rheumatic diseases. Nat Clin Pract Rheumatol 2007, 3(10): 570-9.
19. Aliberti, J., Hieny, S., Reis e Sousa, C., Serhan, C.N. and Sher, A. Lipoxin-mediated inhibition of IL-12 production by DCs: a mechanism for regulation of microbial immunity. Nat Immunol 2002, 3(1): 76-82.
20. Arita, M., Yoshida, M., Hong, S. et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc Natl Acad Sci U S A 2005, 102(21): 7671-6.
21. Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F. and Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int J Cancer 2007, 121(11): 2381-6.
22. Allred, C.D., Talbert, D.R., Southard, R.C., Wang, X. and Kilgore, M.W. PRARgamma1 as a molecular target of eicosapentaenoic acid in human colon cancer (HT-29) cells. J Nutr 2008, 138(2): 250-6.
23. Diep, Q.N., Touyz, R.M. and Schiffrin, E.L. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase. Hypertension 2000, 36(5): 851-5.
24. Zhao, G., Etherton, T.D., Martin, K.R., Vanden Heuvel, J.P., Gillies, P.J., West, S.G. and Kris-Etherton, P.M. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun 2005, 336(3): 909-17.
25. Piva, R., Belardo, G. and Santoro, M.G. NF-kappaB: a stress-regulated switch for cell survival. Antioxid Redox Signal 2006, (3-4): 478-86.
26. Hering, J., Garrean, S., Dekoj, T.R. et al. Inhibition of proliferation by omega-3 fatty acids in chemoresistant pancreatic cancer cells. Ann Surg Oncol 2007, 14(12): 3620-8.
27. Derecka, K., Sheldrick, E.L., Wathes, D.C., Abayasekara, D.R. and Flint, A.P. A PPAR-independent pathway to PUFA-induced COX-2 expression. Mol Cell Endocrinol 2008,287(1-2): 65-71.
28. Szymezak, M., Murray, M. and Petrovic, N. Modulation of angiogenesis by omega-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood 2008, 111(7): 3514-21.
29. Shaikh, S.R. and Edidin, M. Polyunsaturated fatty acids, membrane organization, T cells, and antigen presentation. Am J Clin Nutr 2006, 84(6): 1277-89.
30. Chapkin, R.S., McMurray, D.N., Davidson, L.A., Patil, B.S., Fan, Y.Y. and Lupton, J.R. Bioactive dietary long-chain fatty acids: emerging mechanisms of action. Br J Nutr 2008, 20: 1-6.
31. Chen, W., Jump, D.B., Esselman, W.J. and Busik, J.V. Inhibition of cytokine signaling in human retinal endothelial cells through modification of caveolae/lipid rafts by docosahexaenoic acid. Invest Ophthalmol Vis Sci 2007, 48(1): 18-26.
32. Fer, M., Dréano, Y., Lucas, D., Corcos, L., Salaün, J.P., Berthou, F. and Amet, Y. Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch Biochem Biophys 2008, 471(2): 116-25.
33. Yao, H.T., Chang, Y.W., Lan, S.J., Chen, C.T., Hsu, J.T. and Yeh, T.K. The inhibitory effect of polyunsaturated fatty acids on human CYP enzymes. Life Sci 2006, 79(26): 2432-40.
34. Hammamieh, R., Chakraborty, N., Miller, S.A. et al. Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat 2007, 101(1): 7-16.
35. Schley, P.D., Brindley, D.N. and Field, C.J. (n-3) PUFA alter raft lipid composition and decrease epidermal growth factor receptor levels in lipid rafts of human breast cancer cells. J Nutr 2007, 137(3): 548-53.
36. Luu, N.T., Madden, J., Calder, P.C. et al. Dietary supplementation with fish oil modifies the ability of human monocytes to induce an inflammatory response. J Nutr 2007, 137(12): 2769-74.
37. Yaqoob, P. and Calder, P.C. Fatty acids and immune function: New insights into mechanisms. Br J Nutr 2007, 98(Suppl. 1): S41-5.
38. Kenar, L., Karayilanoglu, T., Aydin, A., Serdar, M., Kose, S. and Erbil, M.K. Protective effects of diets supplemented with omega-3 polyunsaturated Fatty acids and calcium against colorectal tumor formation. Dig Dis Sci 2008, 53(8): 2177-82.
39. MacLean, C.H., Newberry, S.J., Mojica, W.A. et al. Effects of omega-3 fatty acids on cancer risk: a systematic review. JAMA 2006 295(4): 403-15.
40. Poppitt, S.D., Kilmartin, P., Butler, P. and Keogh, G.F. Assessment of erythrocyte phospholipid fatty acid composition as a biomarker for dietary MUFA, PUFA or saturated fatty acid intake in a controlled cross-over intervention trial. Lipids Health Dis 2005, 4: 30.
41. Fuhrman, B.J., Barba, M., Krogh, V. et al. Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab 2006, 50(2): 95-102.
42. Kuriki, K., Hirose, K., Wakai, K. et al. Breast cancer risk and erythrocyte compositions of n-3 highly unsaturated fatty acids in Japanese. Int J Cancer 2007, 121(2): 377-85.
43. Shannon, J., King, I.B., Moshofsky, R., Lampe, J.W., Gao, D.L., Ray, R.M. and Thomas, D.B. Erythrocyte fatty acids and breast cancer risk: a case-control study in Shanghai, China. Am J Clin Nutr 2007, 85(4): 1090-7.
44. Astorg, P. Dietary N-6 and N-3 polyunsaturated fatty acids and prostate cancer risk: a review of epidemiological and experimental evidence. Cancer Causes Control 2004, 15(4): 367-86.
45. Terry, P.D., Terry, J.B. and Rohan, T.E. Long-chain (n-3) fatty acid intake and risk of cancers of the breast and the prostate: recent epidemiological studies, biological mechanisms, and directions for future research. J Nutr 2004, 134(12 Suppl.): 3412S-20S.
46. Leitzmann, M.F., Stampfer, M.J., Michaud, D.S., Augustsson, K., Colditz, G.C., Willett, W.C. and Giovannucci, E.L. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 2004, 80(1): 204-16.
47. Ritch, C.R., Wan, R.L., Stephens, L.B. et al. Dietary fatty acids correlate with prostate cancer biopsy grade and volume in Jamaican men. J Urol 2007, 177(1): 97-101.
48. Kobayashi, N., Barnard, R.J., Henning, S.M. et al. Effect of altering dietary omega-6/omega-3 fatty acid ratios on prostate cancer membrane composition, cyclooxygenase-2, and prostaglandin E2. Clin Cancer Res 2006, 12(15): 4662-70.
49. Kato, I., Akhmedkhanov, A., Koenig, K., Toniolo, P.G., Shore, R.E. and Riboli, E. Prospective study of diet and female colorectal cancer: The New York University Women's Health Study. Nutr Cancer 1997, 28(3): 276-81.
50. Kimura, Y., Kono, S., Toyomura, K. et al. Meat, fish and fat intake in relation to subsite-specific risk of colorectal cancer: The Fukuoka Colorectal Cancer Study. Cancer Sci 2007, 98(4): 590-7.
51. Kuriki, K., Wakai, K., Hirose, K. et al. Risk of colorectal cancer is linked to erythrocyte compositions of fatty acids as biomarkers for dietary intakes of fish, fat, and fatty acids. Cancer Epidemiol Biomarkers Prev 2006, 15(10): 1791-8.
52. Hilakivi-Clarke, L., Olivo, S.E., Shajahan, A. et al. Mechanisms mediating the effects of prepubertal (n-3) polyunsaturated fatty acid diet on breast cancer risk in rats. J Nutr 2005, 135(12 Suppl.): 2946S-52S.